Epilepsy Research Program in New York and New Jersey
The Clinical Research Program is dedicated to improving our patients' lives by finding new ways to treat seizures and epilepsy. The scope of the research is wide and includes all types of seizures and epilepsy from babies to the elderly. Areas of particular interest include women's issues in epilepsy, tumor-related epilepsy, new tools to localize a seizure focus for surgery such as magneto-encephalography (MEG), epileptic seizures which occur in the intensive care unit, new medications for children and adults with epilepsy, laser therapy for epilepsy, and neuropsychological factors of epilepsy and psychogenic non epileptic seizures.
Our group collaborates with other leading epilepsy researchers throughout the United States and other countries. NEREG is part of the Epilepsy Study Consortium, a group of academic centers dedicated to accelerating the development of new therapies for epilepsy, and the Critical Care EEG Monitoring Research Consortium, which is a group of academic centers dedicated to understanding epileptic seizures which occur in the intensive care unit setting. NEREG is also in the process of founding two new multi-center consortiums: the tumor-related epilepsy consortium and a consortium of private epilepsy centers. We also collaborate with other leading researchers to develop new dietary treatments for epilepsy.
We see clinical research as an extension of good clinical care. Just as with good everyday clinical care, there has to be excellent communication between the medical staff and patient. Our team is very experienced, and we take the time to carefully explain the risks and benefits of all of our studies and answer all questions. Participating in a research study is always optional. Joining a clinical trial is a great opportunity to have access to new medical treatments which may not otherwise be available, under very close medical supervision, and also to foster a better understanding of seizures and epilepsy. Study visits and medications may be provided for free (depending on the study). Please take the time to review our open studies and feel free to contact us if you are interested.
Clinical Research Coordinator
Munazza Malik, MD
(201) 343-6676
munazza.malik@gmail.com
MISSING SUMMARY OF PROGRAM being sent in by Dr. Fertig
List of current Northeast Regional Epilepsy Group studies
1) An evaluation of Epilepsy and women’s health issues.
2) A Randomized , open-Label, Multicenter, Parallel-Group, Exploratory study to evaluate the efficacy of intravenous Brivaracetam and intravenous phenytoin in subjects experiencing nonconvulsive electrographic seizures.
3) An Open -Label Safety Extension of the Artemis 1 study of USL261 in the Outpatient Treatment of Subjects with seizure clusters.
4) A Randomized, Double –Blind, Placebo-Controlled Study of the Safety and Efficacy of Intranasal Midazolam (USL261) in the outpatient Treatment of Subjects with Seizure Clusters
5) A Study to prospectively evaluate the effects of MRI-guided laser ablation of epileptogenic foci in patients with treatment resistant partial epilepsy.
6) An open label randomized study Prospectively Examining the effect on Anxiety in partial epilepsy patients treated with Pregabalin
7) Cognitive and behavioral effects of Lacosamide as adjunctive therapy in patients with partial epilepsy.
